NCT02649790 · Interventional trial
Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications
Overall registry status Completed
Phase 1 · Phase 2
Conditions Acute Myeloid Leukemia (AML), Higher-Risk Myelodysplastic Syndrome (HR-MDS), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Metastatic Colorectal Cancer (mCRC), Newly Diagnosed Intermediate/High-Risk MDS, Relapsed/Refractory Multiple Myeloma (RRMM)
Delaware Valley sites
- University of Pennsylvania Abramson Cancer Center Clinical Research Unit · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory